Cerebral angiography with iohexol. A comparison with metrizamide in man

The new non-ionic contrast medium iohexol was compared with Amipaque in selective cerebral angiography in a double blind study in 60 patients. There were no adverse reactions or reports of discomfort during the examinations or in the 24 h follow-up period. No differences were observed with regard to image quality or cerebral circulation time.